← Leaderboards
Manjari Dimri
George Washington University
$318,000
Attributed
$318,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $79.8K · FY2015–19$100K$75K$50K$25K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$318,000 · 2
By mechanism
R03$318,000 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Tumor Suppressor Proteins”
- Scott W Lowe · Sloan-Kettering Inst Can Research$30,621,807
- Carol Prives · Icahn School Of Medicine At Mount Sinai$25,974,663
- Pier Paolo Pandolfi · Sloan-Kettering Institute For Cancer Res$25,707,040
- Xinbin Chen · Medical College Of Georgia (Mcg)$23,449,975
- Carlo M Croce · Thomas Jefferson University$21,878,300
- Wei Gu · Columbia University Health Sciences$21,628,257
Research focus
Tumor Suppressor ProteinsBreast Cancer CellNeoplasm MetastasisTumorBreast Cancer PatientCancer Stem CellMalignant Breast NeoplasmMalignant NeoplasmsPhenotypeResistanceChemotherapyProteinsPharmaceutical PreparationsOverexpressionGenesGrowthEpigenomeComplexEzh2 GeneAnti-InflammatoryBreast Cancer PreventionClinical CareFutureCell Culture Techniques
Grant awards (4)
A novel regulator of triple negative breast cancer and breast cancer stem cell phenotype$79,750
R03 · FY2019 · CA · contact PI
A novel regulator of triple negative breast cancer and breast cancer stem cell phenotype$79,750
R03 · FY2018 · CA · contact PI
A chemopreventive approach of targeting breast cancer stem cells$79,250
R03 · FY2016 · CA · contact PI
A chemopreventive approach of targeting breast cancer stem cells$79,250
R03 · FY2015 · CA · contact PI